Study Finds Women with Alzheimer’s Have Lower Levels of Healthy Fats

New research shows women with Alzheimer’s have lower levels of healthy fats, especially omega-3s, pointing to potential dietary strategies for prevention and management.
Women diagnosed with Alzheimer’s disease tend to have reduced levels of beneficial fats, particularly omega-3 fatty acids, compared to healthy women. A recent study from the UK analyzed lipid profiles in men and women with and without Alzheimer’s, revealing significant differences in women’s lipid levels. Women with the disease showed decreased levels of unsaturated lipids containing omega-3s like DHA and EPA, alongside an increase in unhealthy fats. Interestingly, no similar lipid pattern was observed in men with Alzheimer’s. Researchers suggest that boosting omega-3 intake through foods such as salmon, flaxseed, and edamame may offer protective benefits for women at risk. The study emphasizes the importance of personalized approaches in Alzheimer’s research and highlights potential dietary strategies to support brain health. While more research is needed, these findings underscore the role of lipid health in cognitive decline and disease prevention.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Moving Beyond 'One Gene, One Disease': Embracing Genetic Complexity for Personalized Medicine
Understanding the complex interactions between multiple genetic variants is essential for advancing personalized medicine and improving disease prediction and treatment strategies.
Chickenpox Vaccination Policies: UK Approves the MMRV for Under-Fours Amid US Restrictions
The UK and US adopt contrasting policies on chickenpox vaccination for young children, with the UK approving the MMRV vaccine to enhance coverage, while the US restricts its use due to safety concerns. Learn about the implications for public health and childhood immunity.
New Insights into Reducing Liver Cancer Risk for Individuals with Hepatitis B
Groundbreaking research reveals how combining statin therapy with traditional HBV treatments may lower liver cancer risk by targeting immune dysregulation and environmental carcinogen pathways. Read more about new strategies for preventing hepatocellular carcinoma in hepatitis B patients.
Innovative Drug Shows Promise in Managing Resistant Hypertension
A new clinical trial highlights lorundrostat's potential to safely lower blood pressure in patients with resistant hypertension, marking a significant advancement in targeted hypertension therapy.



